Upregulating MAPK8IP1P2 inhibited, while silencing MAPK8IP1P2 enhanced anoikis resistance in vitro and lymphatic metastasis of thyroid cancer cells in vivo. This evidence concerns the gene MAPK8IP1P2 and thyroid gland carcinoma.